Author： Adis International Limited
Publisher： Adis International
ISSN： 1176-3469
Source： Pharmaceutical & Diagnostic Innovation, Vol.4, Iss.4, 2006-01, pp. : 7-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Aminopeptidase A inhibitors: new hype for hypertension?
Inpharma, Vol. 1, Iss. 1640, 2008-01 ,pp. :
Access to resources
Recommend
CER − evolution or revolution?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. :
Bevacizumab and hypertension: a Catch-22?
Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. :
Gene therapy for pulmonary hypertension?
Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. :
ACE inhibitors preferable in hypertension?
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :